Home/Sisu Pharma/Sean E. O'Brien, Ph.D.

SE

Sean E. O'Brien, Ph.D.

Founder, Chief Executive Officer

Therapeutic Areas

Oncology Neurodegenerative Diseases Infectious Diseases

Sisu Pharma Pipeline

Drug	Indication	Phase
HSF1 Degrader Program	Oncology (Therapy-resistant cancers)	Pre-clinical
HSF1 Activator Program	Neurodegenerative Diseases	Pre-clinical
HSF1 Modulator Program	Infectious Diseases	Pre-clinical

Leadership Team at Sisu Pharma

Dennis J. Thiele, Ph.D.

Founder, Chief Scientific Officer, Member Scientific Advisory Board

Jiaoti Huang, M.D., Ph.D.

Founder, Chair Scientific Advisory Board

Michael E. Jung, Ph.D.

Member, Scientific Advisory Board

View full Sisu Pharma profile